An observational study in Polynesian Bronchiectasis, sponsored by Centre Hospitalier Intercommunal Creteil. Recruiting at 1 site in French Polynesia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-15.
Sponsored by Centre Hospitalier Intercommunal Creteil · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The study hypothesis is that dilations of idiopathic bronchi are particularly common in French Polynesia, and that there are arguments in favour of an underlying genetic factor.
The study will retrieve retrospective data in the history of bronchial dilation, patients' personal and family history, microbiological and scannographic data, and the latest cardio respiratory checkup.
21 studies on the registry are indexed under Kartagener Syndrome; 4 are open to participants now.
This study's planned enrollment of 500 is above the median of 200 across 17 observational studies indexed under Kartagener Syndrome.
Browse Kartagener Syndrome studies →Centre Hospitalier Intercommunal Creteil is the lead sponsor of 132 studies on the registry; 37 are open to participants now.
Counted across the registry records on this site, refreshed daily.
500 patients with bronchial dilatation over the study period: Jan 1, 2010 to Dec 31, 2020
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Describe the detailed phenotype of bronchi dilation in the Polynesian population
* Clinical criteria: age of onset, personal or family history, smoking Changes in respiratory function * Infectious complications: types of bronchial colonization (bacterial, mycobacterial and mycological) * Scantographic aspect: Appearance of bronchectasis: cylindrical, varicose orcious, cystic Distributions: LSD, LM, LID, LSG, LIG
Time frame: Day 1
Highlighting indirect arguments for a genetic cause
Age of onset of symptoms, frequency of so-called "idiopathic" bronchi dilatation, frequency of inbreeding, familial history
Time frame: Day 1
Ran from Jun 2025 to primary completion in Jul 2025, 1 month.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Intercommunal Creteil →